Nima Naderi Selected Research

Nima Naderi Research Topics

Disease

8	Epilepsy (Aura) 05/2022 - 11/2008
5	Pain (Aches) 01/2021 - 05/2005
5	Infarction (Infarctions) 12/2020 - 01/2017
4	Seizures (Absence Seizure) 01/2019 - 07/2013
3	Edema (Dropsy) 01/2021 - 08/2007
3	Ischemia 12/2020 - 01/2018
3	Cognitive Dysfunction 01/2019 - 01/2018
3	Neoplasms (Cancer) 01/2019 - 01/2013
2	Stroke (Strokes) 04/2019 - 01/2017
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2019 - 01/2017
2	Temporal Lobe Epilepsy 01/2019 - 04/2016
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 01/2013
2	Neuroinflammatory Diseases 01/2019 - 01/2017
2	Multiple Sclerosis 01/2016 - 01/2015
2	Alzheimer Disease (Alzheimer's Disease) 01/2015 - 01/2013
2	Asthma (Bronchial Asthma) 08/2013 - 01/2013
1	Rabies (Hydrophobia) 07/2022
1	Atherosclerosis 04/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2021
1	Nervous System Diseases (Neurological Disorders) 12/2020
1	Cerebral Infarction 04/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2017
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2016
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2015
1	Demyelinating Diseases (Demyelinating Disease) 06/2013

Drug/Important Bio-Agent (IBA)

5	Formaldehyde (Formol)FDA Link 01/2021 - 05/2005
4	CannabinoidsIBA 04/2012 - 05/2005
3	Anticonvulsants (Antiepileptic Drugs)IBA 05/2022 - 02/2012
3	Pilocarpine (Ocusert)FDA LinkGeneric 01/2019 - 01/2015
3	salicylhydroxamic acid (SHAM)IBA 01/2019 - 01/2018
2	CarrageenanIBA 01/2021 - 08/2007
2	Atorvastatin (Lipitor)FDA Link 04/2019 - 01/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2019 - 01/2017
2	Galectin 3 (LGALS3)IBA 01/2019 - 01/2013
2	citrus pectinIBA 01/2019 - 01/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 01/2013
2	CytokinesIBA 01/2019 - 01/2018
2	Neuroprotective AgentsIBA 01/2019 - 01/2018
2	CannabidiolIBA 04/2016 - 07/2013
2	palmidrolIBA 11/2015 - 04/2012
2	Codon (Codons)IBA 08/2013 - 01/2013
1	Glycoproteins (Glycoprotein)IBA 07/2022
1	anandamide (arachidonylethanolamide)IBA 05/2022
1	Pentylenetetrazole (Metrazol)IBA 11/2021
1	Acrolein (Aqualin)IBA 04/2021
1	ethyl acetateIBA 01/2021
1	Chloroform (Trichloromethane)IBA 01/2021
1	aniline (aniline hydrobromide)IBA 12/2020
1	pluronic-chitosanIBA 12/2020
1	HydrogelsIBA 12/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2020
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 12/2020
1	Malondialdehyde (Propanedial)IBA 04/2019
1	fluoro jadeIBA 04/2019
1	coenzyme Q10 (CoQ10)IBA 04/2019
1	8-Hydroxy-2'-DeoxyguanosineIBA 04/2019
1	benzimidazoleIBA 01/2019
1	tyrosine receptor (receptor, tyrosine)IBA 01/2019
1	CrizotinibIBA 01/2019
1	Toll-Like Receptor AgonistsIBA 01/2019
1	BenzoxazolesIBA 01/2019
1	ChloridesIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	Naltrexone (ReVia)FDA LinkGeneric 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Cell Surface ReceptorsIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	IntegrinsIBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	Lipid AIBA 01/2018
1	monophosphoryl lipid AIBA 01/2018
1	phthalimideIBA 01/2018
1	Saline SolutionIBA 01/2018
1	PotassiumIBA 01/2017
1	CalciumIBA 01/2017
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 04/2016
1	AntioxidantsIBA 04/2016
1	MercuryIBA 01/2016
1	iodopravadoline (AM 630)IBA 11/2015
1	Potassium Channels (Potassium Channel)IBA 01/2015
1	Ion Channels (Ion Channel)IBA 01/2015
1	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2013
1	Fluticasone (Cutivate)FDA LinkGeneric 08/2013
1	Salmeterol Xinafoate (Serevent)FDA Link 08/2013
1	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 08/2013
1	arginylarginine (Arg-Arg)IBA 08/2013
1	paxillineIBA 07/2013
1	Luxol Fast Blue MBS (Luxol fast blue)IBA 06/2013

Therapy/Procedure

2	Therapeutics 01/2015 - 01/2013
1	Deep Brain Stimulation 12/2021
1	Injections 12/2020
1	Secondary Prevention 04/2019
1	Intraperitoneal Injections 01/2019
1	Aftercare (After-Treatment) 04/2016